37
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Racial Disparities in Medication Use During Pregnancy: Results from the NISAMI Cohort

ORCID Icon, , , , , , , , & show all
Pages 2755-2775 | Received 13 Jan 2024, Accepted 29 May 2024, Published online: 05 Jun 2024

References

  • Stanley AY, Durham CO, Sterrett JJ, Wallace JB. Safety of over-the-counter medications in pregnancy. MCN Am J Matern Nurs. 2019;44(4):196. doi:10.1097/NMC.0000000000000537
  • Lunardi-Maia T, Schuelter-Trevisol F, Galato D. Uso de medicamentos no primeiro trimestre de gravidez: avaliação da segurança dos medicamentos e uso de ácido fólico e sulfato ferroso. Rev Bras Ginecol E Obstetrícia. 2014;36(12):541–547. doi:10.1590/So100-720320140005051
  • Smolina K, Hanley GE, Mintzes B, Oberlander TF, Morgan S, Fischer G. Trends and determinants of prescription drug use during pregnancy and postpartum in british columbia, 2002–2011: a population-based cohort study. PLoS One. 2015;10(5):e0128312. doi:10.1371/journal.pone.0128312
  • Costa DB, Coelho HLL, Santos DB. Utilização de medicamentos antes e durante a gestação: prevalência e fatores associados. Cad Saúde Pública. 2017;33:e00126215. doi:10.1590/0102-311X00126215
  • Engeland A, Bjørge T, Klungsøyr K, Hjellvik V, Skurtveit S, Furu K. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiol Drug Saf. 2018;27(9):995–1004. doi:10.1002/pds.4577
  • Bérard A, Abbas-Chorfa F, Kassai B, et al. The French Pregnancy Cohort: medication use during pregnancy in the French population. PLoS One. 2019;14(7):e0219095. doi:10.1371/journal.pone.0219095
  • Donald S, Sharples K, Barson D, Horsburgh S, Parkin L. Patterns of prescription medicine dispensing before and during pregnancy in New Zealand, 2005–2015. PLoS One. 2020;15(6):e0234153. doi:10.1371/journal.pone.0234153
  • Haas DM, Marsh DJ, Dang DT, et al. Prescription and other medication use in pregnancy. Obstet Gynecol. 2018;131(5):789. doi:10.1097/AOG.0000000000002579
  • Lutz BH, Miranda VIA, Silveira MPT, et al. Medication use among pregnant women from the 2015 Pelotas (Brazil) birth cohort study. Int J Environ Res Public Health. 2020;17(3):989. doi:10.3390/ijerph17030989
  • Lupattelli A, Spigset O, Twigg MJ, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4(2):e004365. doi:10.1136/bmjopen-2013-004365
  • Havard A, Barbieri S, Hanly M, et al. Medications used disproportionately during pregnancy: priorities for research on the risks and benefits of medications when used during pregnancy. Pharmacoepidemiol Drug Saf. 2021;30(1):53–64. doi:10.1002/pds.5131
  • Goes EF, Ferreira AJF, Ferreira AJF. Desigualdades raciais em saúde e a pandemia da Covid-19. Trab Educ E Saúde. 2020;18(3):e00278110. doi:10.1590/1981-7746-sol00278
  • Araújo EM, Caldwell KL, Santos MPA, et al. Morbimortalidade pela Covid-19 segundo raça/cor/etnia: a experiência do Brasil e dos Estados Unidos. Saúde Em Debate. 2021;44(spe4):191–205. doi:10.1590/0103-11042020E412
  • Kalckmann S, Santos CG, Batista LE, Cruz VM. Racismo institucional: um desafio para a eqüidade no SUS? Saúde E Soc. 2007;16:146–155. doi:10.1590/S0104-12902007000200014
  • López LC. O conceito de racismo institucional: aplicações no campo da saúde. Interface Comun Saúde Educ. 2012;16(40):121–134. doi:10.1590/S1414-32832012005000004
  • Fonseca JM, Rocha PRH, Rocha PRH, et al. Racial inequality in perinatal outcomes in two Brazilian birth cohorts. Braz J Med Biol Res. 2021;54(1):e10120. doi:10.1590/1414-431X202010120
  • Guimarães JMN, Yamada G, Barber S, et al. Racial inequities in self-rated health across Brazilian cities: does residential segregation play a role? Am J Epidemiol. 2022;191(6):1071–1080. doi:10.1093/aje/kwac001
  • Silva NN, Favacho VBC, Boska GA, Andrade EC, Merces NP, Oliveira MAF. Access of the black population to health services: integrative review. Rev Bras Enferm. 2020;73(4):e20180834. doi:10.1590/0034-7167-2018-0834
  • Oliveira KA, Araújo EM, Casotti CA, Silva CAL, Santos DB, Santos DBD. Associação entre raça/cor da pele e parto prematuro: revisão sistemática com meta-análise. Rev Saúde Pública. 2018;52:26. doi:10.11606/S1518-8787.2018052000406
  • Sachdeva P, Patel BG, Patel BK. Drug Use in Pregnancy; a Point to Ponder! Indian J Pharm Sci. 2009;71(1):1–7. doi:10.4103/0250-474X.51941
  • Schiff DM, Nielsen T, Hoeppner BB, et al. Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts. JAMA Network Open. 2020;3(5):e205734. doi:10.1001/jamanetworkopen.2020.5734
  • Vafai Y, Yeung EH, Sundaram R, et al. Racial/ethnic differences in prenatal supplement and medication use in low-risk pregnant women. Am J Perinatol. 2022;39(6):623–632. doi:10.1055/s-0040-1717097
  • Bachhav SS, Kshirsagar NA. Systematic review of drug utilization studies & the use of the drug classification system in the WHO-SEARO Region. Indian J Med Res. 2015;142(2):120–129. doi:10.4103/0971-5916.164223
  • Instituto Brasileiro de Geografia e Estatística. Cidades: Santo Antônio de Jesus. IBGE; 2011. Available from: https://cidades.ibge.gov.br/brasil/ba/santo-antonio-de-jesus/panorama. Accessed May 30, 2024.
  • Castro CT, Pereira M, Santos DB. Association between paracetamol use during pregnancy and perinatal outcomes: prospective NISAMI cohort. PLoS One. 2022;17(4):e0267270. doi:10.1371/journal.pone.0267270
  • Costa DB, Castro CT, Gama RS, Santos DB. Drug use according to risk classification and associated factors among pregnant women: results from NISAMI cohort. Res Soc Dev. 2020;9(12):e43691211247–e43691211247. doi:10.33448/rsd-v9i12.11247
  • WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology & WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. Introduction to Drug Utilization Research. World Health Organization; 2003. Available from: https://apps.who.int/iris/handle/10665/42627. Accessed May 30, 2024.
  • Agência Nacional de Vigilância Sanitária. Resolução Da Diretoria Colegiada No 60, de 17 de Dezembro de 2010. ANVISA; 2010.
  • R Core Team. R: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2023. Available from: https://www.R-project.org. Accessed May 30, 2024.
  • Zeileis A, Lumley T, Graham N, Koell S. sandwich: robust covariance matrix estimators; 2023. Available from: https://cran.r-project.org/web/packages/sandwich/index.html. Accessed April 20, 2024.
  • Hothorn T, Zeileis A. lmtest: testing linear regression models; 2022. Available from: https://cran.r-project.org/web/packages/lmtest/index.html. Accessed April 20, 2024.
  • Zhang J, Ung COL, Guan X, Shi L. Safety of medication use during pregnancy in mainland China: based on a national health insurance database in 2015. BMC Pregnancy Childbirth. 2019;19(1):459. doi:10.1186/s12884-019-2622-y
  • Persell SD, Karmali KN, Lee JY, et al. Associations between health literacy and medication self-management among community health center patients with uncontrolled hypertension. Patient Prefer Adherence. 2020;14:87–95. doi:10.2147/PPA.S226619
  • Pagán JA, Ross S, Yau J, Polsky D. Self-medication and health insurance coverage in Mexico. Health Policy. 2006;75(2):170–177. doi:10.1016/j.healthpol.2005.03.007
  • Tuha A, Faris AG, Mohammed SA, Gobezie MY. Self-medication and associated factors among pregnant women attending antenatal care at kemisie general hospital, North East Ethiopia. Patient Prefer Adherence. 2020;14:1969–1978. doi:10.2147/PPA.S277098
  • Chaudhry SI, Herrin J, Phillips C, et al. Racial disparities in health literacy and access to care among patients with heart failure. J Card Fail. 2011;17(2):122–127. doi:10.1016/j.cardfail.2010.09.016
  • Ylitalo KR, Meyer MRU, Lanning BA, During C, Laschober R, Griggs JO. Simple screening tools to identify limited health literacy in a low-income patient population. Medicine. 2018;97(10):e0110. doi:10.1097/MD.0000000000010110
  • Rikard RV, Thompson MS, McKinney J, Beauchamp A. Examining health literacy disparities in the United States: a third look at the National Assessment of Adult Literacy (NAAL). BMC Public Health. 2016;16(1):975. doi:10.1186/s12889-016-3621-9
  • Pacheco VC, Silva JC, Mariussi AP, Lima MR, Silva TR. As influências da raça/cor nos desfechos obstétricos e neonatais desfavoráveis. Saúde Em Debate. 2018;42:125–137. doi:10.1590/0103-1104201811610
  • Diehl EE, Almeida LK. Medicamentos em contexto local indígena: a “farmácia caseira” Xokleng, Santa Catarina. Rev Antropol UFSCar. 2012;4(1):189–206. doi:10.52426/rau.v4i1.70
  • Liu D, Cheng Y, Dang S, et al. Maternal adherence to micronutrient supplementation before and during pregnancy in Northwest China: a large-scale population-based cross-sectional survey. BMJ Open. 2019;9(8):e028843. doi:10.1136/bmjopen-2018-028843
  • Tuncalp Ö, Rogers LM, Lawrie TA, et al. WHO recommendations on antenatal nutrition: an update on multiple micronutrient supplements. BMJ Glob Health. 2020;5(7):e003375. doi:10.1136/bmjgh-2020-003375
  • Frayne J, Pinchon D. Anemia in pregnancy. Aust J Gen Pract. 2019;48:125–129.
  • Harrison RK, Lauhon SR, Colvin ZA, McIntosh JJ. Maternal anemia and severe maternal morbidity in a US cohort. Am J Obstet Gynecol MFM. 2021;3(5). doi:10.1016/j.ajogmf.2021.100395
  • Branum AM, Bailey R, Singer BJ. Dietary supplement use and folate status during pregnancy in the United States. J Nutr. 2013;143(4):486–492. doi:10.3945/jn.112.169987
  • Smith C, Teng F, Branch E, Chu S, Joseph KS. Maternal and perinatal morbidity and mortality associated with anemia in pregnancy. Obstet Gynecol. 2019;134(6):1234. doi:10.1097/AOG.0000000000003557
  • Kennon-McGill S, McGill MR. Extrahepatic toxicity of Acetaminophen: critical evaluation of the evidence and proposed mechanisms. J Clin Trans Res. 2017;3(3):297–310.
  • Gou X, Wang Y, Tang Y, et al. Association of maternal prenatal Acetaminophen use with the risk of attention deficit/hyperactivity disorder in offspring: a meta-analysis. Aust N Z J Psychiatry. 2019;53(3):195–206. doi:10.1177/0004867418823276
  • Mengue SS, Schenkel EP, Duncan BB, Schmidt MI. Uso de medicamentos por gestantes em seis cidades brasileiras. Rev Saúde Pública. 2001;35:415–420. doi:10.1590/S0034-89102001000500002
  • Hansen C, Desrosiers TA, Wisniewski K, Strickland MJ, Werler MM, Gilboa SM. Use of antihistamine medications during early pregnancy and selected birth defects: the national birth defects prevention study, 1997–2011. Birth Defects Res. 2020;112(16):1234–1252. doi:10.1002/bdr2.1749
  • Garcia Saborio OE, Hines BK, Wesselman J. Safe management of nausea and vomiting during pregnancy in the emergency department. Adv Emerg Nurs J. 2019;41(4):336. doi:10.1097/TME.0000000000000258
  • Volqvartz T, Vestergaard AL, Aagaard SK, et al. Use of stimulants, over-the-counter and prescription drugs among Danish pregnant women. Basic Clin Pharmacol Toxicol. 2020;127(3):205–210. doi:10.1111/bcpt.13396
  • Trønnes JN, Lupattelli A, Nordeng H. Safety profile of medication used during pregnancy: results of a multinational European study. Pharmacoepidemiol Drug Saf. 2017;26(7):802–811. doi:10.1002/pds.4213
  • Alema NM, Semagn G, Melesse S, et al. Patterns and determinants of prescribed drug use among pregnant women in Adigrat general hospital, northern Ethiopia: a cross-sectional study. BMC Pregnancy Childbirth. 2020;20(1):624. doi:10.1186/s12884-020-03327-7
  • Navaro M, Vezzosi L, Santagati G, Angelillo IF, Group CW. Knowledge, attitudes, and practice regarding medication use in pregnant women in Southern Italy. PLoS One. 2018;13(6):e0198618. doi:10.1371/journal.pone.0198618
  • Mengue SS, Schenkel EP, Schmidt MI, Duncan BB. Fatores associados ao uso de medicamentos durante a gestação em seis cidades brasileiras. Cad Saúde Pública. 2004;20:1602–1608. doi:10.1590/S0102-311X2004000600018
  • Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernández-Díaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. Am J Obstet Gynecol. 2011;205(1):51.e1–51.e8. doi:10.1016/j.ajog.2011.02.029
  • Admon LK, Winkelman TNA, Moniz MH, Davis MM, Heisler M, Dalton VK. Disparities in chronic conditions among women hospitalized for delivery in the United States, 2005–2014. Obstet Gynecol. 2017;130(6):1319. doi:10.1097/AOG.0000000000002357
  • Dillon P, O’Brien KK, McDonnell R, et al. Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study. BMC Pregnancy Childbirth. 2015;15(1):67. doi:10.1186/s12884-015-0489-0
  • Ayad M, Costantine MM. Epidemiology of medications use in pregnancy. Semin Perinatol. 2015;39(7):508–511. doi:10.1053/j.semperi.2015.08.002
  • Beyene KG, Beza SW. Self-medication practice and associated factors among pregnant women in Addis Ababa, Ethiopia. Trop Med Health. 2018;46(1):10. doi:10.1186/s41182-018-0091-z
  • Blotière PO, Damase-Michel C, Weill A, Maura G. Dispensing of potentially harmful prescription drugs in 1.8 million pregnant women in France: a nationwide study based on two risk classification systems. Drug Saf. 2021;44(12):1323–1339. doi:10.1007/s40264-021-01117-4
  • Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3(1):21. doi:10.1186/1471-2288-3-21